Top KHN Original Stories

View More

Total Results: 277

Proposed Gutting Of Drug Czar’s Funding Rolled Back To Just Trims After Vocal Outcry

KHN Morning Briefing

A draft of the president’s budget had shown a proposed 95 percent cut to the office in the middle of an opioid epidemic. But the released plan walks that back. Meanwhile, Food and Drug Administration Commissioner Scott Gottlieb is calling on his staff to increase efforts to fight the crisis sweeping the country.

Quiz: Help Us Take The Pulse Of Our Readers

KHN Original

Even the most exalted among us realize health care policy is complicated. Here’s a pop quiz to see what you have learned as a regular reader of Kaiser Health News.

Drugmakers Would Be Required To Notify HHS, Justify Price Hikes Under New Bill

KHN Morning Briefing

The companies would have to provide manufacturing, R&D, marketing costs, as well as net profits associated with the drugs. In other pharmaceutical news, consolidation and how it’s led to higher drug prices; direct-to-consumer ads and their role in pushing drugs; and what happens when a patient’s body turns against the drugs trying to save them.

Ideas For Tackling Prescription Drug Costs Gain Traction With White House, Lawmakers

KHN Morning Briefing

White House budget director Mick Mulvaney says that the administration is looking at ways to make drugmakers pay for mandatory rebates on medications bought through Medicare, as done with Medicaid. And Health and Human Services Secretary Tom Price will hold listening sessions on the issue in the coming weeks.

For Fourth Straight Year, U.S. Prices On Prescription Drugs Go Up More Than 8%

KHN Morning Briefing

In 2016, the cost of medications rose 8.8 percent. Brand-name medications went up 12.9 percent while generics only increased 0.3 percent. In other pharmaceutical news, Mylan takes issue with a Food and Drug Administration decision not to approve its generic version of GlaxoSmithKline’s Advair.